Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Bioinformatics and Biotechnology

Date Submitted: May 30, 2024
Open Peer Review Period: Jun 4, 2024 - Jul 30, 2024
Date Accepted: Oct 16, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: Scoping Review

Hudon A, Beaudoin M, Phraxayavong K, Potvin S, Dumais A

Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: Scoping Review

JMIR Bioinform Biotech 2024;5:e62752

DOI: 10.2196/62752

PMID: 39546776

PMCID: 11607571

Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: A Scoping Review

  • Alexandre Hudon; 
  • Mélissa Beaudoin; 
  • Kingsada Phraxayavong; 
  • Stéphane Potvin; 
  • Alexandre Dumais

ABSTRACT

Background:

An increasing body of literature highlights the integration of machine learning with genomic data in psychiatry, particularly for complex mental health disorders such as schizophrenia. These advanced techniques offer promising potential for uncovering various facets of these disorders. A comprehensive review of the current applications of machine learning in conjunction with genomic data within this context can significantly enhance our understanding of the current state of research and its future directions.

Objective:

The objective of this study is to conduct a systematic scoping review of the use of machine learning algorithms with genomic data in the field of schizophrenia.

Methods:

A systematic, scoping review, search was performed in the electronic databases of Medline, Web of Science, PsycNet (PsycINFO), and Google Scholar from 2013 to 2024. Studies at the intersection of schizophrenia, genomic data, and machine learning were evaluated.

Results:

The literature search identified 2437 eligible articles after removing duplicates. Following abstract screening, 143 full-text articles were assessed, and 121 were subsequently excluded. Therefore, 21 studies were thoroughly assessed. Various machine learning algorithms were used in the identified studies, with support vector machines being the most common. The studies notably used genomic data to predict schizophrenia, identifying schizophrenia features, discovering drugs, classifying schizophrenia amongst other mental health disorders, and predicting the quality-of-life of patients.

Conclusions:

Several high-quality studies were identified. Yet, the application of machine learning with genomic data in the context of schizophrenia remains limited. Future research is essential to further evaluate the portability of these models and to explore their potential clinical applications.


 Citation

Please cite as:

Hudon A, Beaudoin M, Phraxayavong K, Potvin S, Dumais A

Exploring the Intersection of Schizophrenia, Machine Learning, and Genomics: Scoping Review

JMIR Bioinform Biotech 2024;5:e62752

DOI: 10.2196/62752

PMID: 39546776

PMCID: 11607571

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.